Free Trial
→ 70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (From WealthPress) (Ad) Free ELDN Stock Alerts

Eledon Pharmaceuticals (ELDN) SEC Filings & 10K Form

Eledon Pharmaceuticals logo
$4.29 -0.05 (-1.15%)
Closing price 04:00 PM Eastern
Extended Trading
$4.30 +0.00 (+0.12%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Eledon Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
02/14/2025
4:34 PM		ARMISTICE CAPITAL, LLC (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/14/2025
10:22 AM		Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Frazier Life Sciences Public Fund, L.P. (Filed by)
Form SCHEDULE 13G/A
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Kirk Allan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Robinson James A. Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Lee June (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Smith Bryan E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Perrin Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Katkin Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Little Paul Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Gros David-Alexandre C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
McBride John S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Hillson Jan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
7:00 AM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
4:00 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Gros David-Alexandre C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:00 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Smith Bryan E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:00 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Perrin Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:00 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Little Paul Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:51 PM		ARMISTICE CAPITAL, LLC (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Form SC 13G/A
11/12/2024
4:00 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
3:17 PM		Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
11/05/2024
10:44 AM		Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Frazier Life Sciences Public Fund, L.P. (Filed by)
Form SC 13G
10/31/2024
4:52 PM		BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2024
4:49 PM		BIOTECHNOLOGY VALUE FUND L P (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Form SC 13G/A
10/31/2024
4:50 PM		BIOTECHNOLOGY VALUE FUND L P (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Form SC 13G/A
10/30/2024
5:36 AM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 424B5
10/30/2024
5:24 AM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 424B5
10/29/2024
8:27 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:00 AM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
11:15 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form EFFECT
09/20/2024
4:00 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
3:16 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/19/2024
3:33 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 10-Q/A
08/19/2024
3:36 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/19/2024
3:30 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 10-K/A
08/14/2024
4:12 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form NT 10-Q
08/14/2024
4:15 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
3:30 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:47 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:41 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
11:15 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form EFFECT
05/24/2024
3:02 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
Critical ‘Buy Now’ Alert on My Favorite Stock! (Ad)

My absolute favorite stock just hit a critical "buy now" trigger price.

Click here for the ticker >>>
05/22/2024
6:36 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
05/15/2024
6:00 AM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
4:04 PM		BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
6:15 AM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:30 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2024
3:01 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ELDN) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
NVDA Crash Update
An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...
Chaikin Analytics | Sponsored
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...
Behind the Markets | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
My 2025 AI Blueprint
I first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...
Weiss Ratings | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored
America cannot power AI
There’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...
Porter & Company | Sponsored